25 results
8-K
EX-99.1
SLRN
Acelyrin, Inc.
13 Aug 24
Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial Results
4:14pm
, “said Shoaib Ugradar, MD, Department of Orbital and Oculoplastic Surgery, private practice, Beverly Hills, California. “I am encouraged by this approach
8-K
EX-10.1
SLRN
Acelyrin, Inc.
13 Aug 24
Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial Results
4:14pm
in this Agreement limits Employee’s ability to file a charge or complaint with the Equal Employment Opportunity Commission, the Department of Labor … , the National Labor Relations Board, the Occupational Safety and Health Administration, the California Department of Fair Employment and Housing
8-K
EX-10.1
SLRN
Acelyrin, Inc.
9 May 24
ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones
8:13am
that nothing in this Agreement limits Employee’s ability to file a charge or complaint with the Equal Employment Opportunity Commission, the Department … of Labor, the National Labor Relations Board, the Occupational Safety and Health Administration, the California Department of Fair Employment and Housing
8-K
EX-10.2
0q50 qsfd
9 May 24
ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones
8:13am
10-K
ha98ai4zjsn
28 Mar 24
Annual report
4:21pm
8-K
EX-99.2
ham5tpjlrimej9
11 Mar 24
ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis
8:05am
8-K
EX-10.1
qs9tc0lrxv wp
2 Aug 23
Departure of Directors or Certain Officers
5:05pm
10-Q
opv15w2
15 Jun 23
Quarterly report
4:19pm
8-K
EX-99.1
ssc2t3a aokr8tss1q
9 May 23
ACELYRIN, INC. Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
4:16pm
424B4
8nemj 2yguxmp5
5 May 23
Prospectus supplement with pricing info
4:22pm
S-1/A
EX-10.3
wtnbw
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-1.1
e19ve61a4s032
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-10.9
fkwq6ubx36at62j2x5
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-10.14
mpc0k0c3aw4
1 May 23
IPO registration (amended)
6:10am
S-1/A
qmsvpb
1 May 23
IPO registration (amended)
6:10am